株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の感染症診断検査市場

The World Market for Infectious Disease Diagnostic Tests

発行 Kalorama Information 商品コード 96362
出版日 ページ情報 英文 300 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界の感染症診断検査市場 The World Market for Infectious Disease Diagnostic Tests
出版日: 2015年11月01日 ページ情報: 英文 300 Pages
概要

感染症は、現在、世界の医療デリバリーシステムが直面している最も困難な問題です。WHO(世界保健機関)は、毎年1700万人以上が感染症で死亡しており、これらの多くが院内感染によるものだと推計しています。

当レポートでは、世界の感染症診断検査市場について調査し、今後5年間の感染症検査における動向と技術進歩のレビューを提供しており、試験タイプ別の市場規模・売上予測、主要企業のプロファイルなどをまとめた結果をお届けいたします。

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • 発展する世界の感染症検査:イントロダクション
    • 公衆衛生の反応
    • 資金源
  • 主な疾患の脅威
  • 主な感染症検査技術
  • 見解

第3章 感染症検査の動向

  • 背景
  • 新しい感染症のグローバル化
    • 貿易と旅行によるグローバル化
    • 第三世界における疾病負担
  • ワクチン
  • 微生物の抗生物質耐性に対する脅威の増大
  • POC検査
  • 感染症検査における新技術プラットフォーム
    • リアルタイムPCR
    • 代替核酸増幅法
    • LAMP法
    • NEAR
    • SDA
    • HDA
    • NASBA
    • TMA
    • シーケンシング
    • 質量分析法
    • フローサイトメトリー
  • まとめ

第4章 市場分析の概要

  • 背景
    • 感染症検査の世界市場
    • 感染症検査市場;ID/AST、免疫測定、分子測定
    • 世界市場における主要企業
    • 市場で主流の感染症

第5章 微生物ID/AST検査

  • 背景
  • IDおよび抗生物質感受性試験(AST)
  • 市場分析
  • 地域別内訳
  • 市場シェア
    • 簡易検査
    • 微生物同定/抗菌薬感受性システム
    • 発色媒体
    • 血液培養
    • 血液培養ID検査のベンダーの発展
  • ID/AST検査の市場展望

第6章 免疫測定市場

  • 背景
  • 敗血症血清学
  • 肝炎
  • HIV
  • 菌類学
  • 寄生虫学
  • 呼吸器系
  • ToRCH症候群
  • 性感染症(STD)
  • 地域的内訳
  • 免疫測定法感染症検査市場の展望

第7章 分子測定市場

  • 背景
  • 市場分析
    • 院内感染(HAI)市場
    • HIV市場
    • 肝炎市場
    • クラミジア/淋病(CT/NG)
    • HPV(ヒト・パピローマ)
    • 呼吸器系
    • 結核/TB
    • その他
  • クラミジア/淋病(CT/NG) 、HPV(ヒト・パピローマ)および性感染症(STD);女性の健康
  • 院内感染(HAI)/抗菌薬耐性(AMR)
  • HIV
  • 呼吸器系
  • 分子感染症検査市場の展望

第8章 感染症向け血液スクリーニング市場

  • 血液スクリーニングで一般的に検査する病原体
  • 市場分析(種類別)
  • 免疫測定法
  • 核酸検査(NAT)
  • 核酸検査(NAT)の導入と革新

第9章 企業プロファイル

  • Abbott Diagnostics
  • Alere
  • Becton, Dickinson and Company (BD)
  • bioMerieux Inc.
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Copan Diagnostics
  • DiaSorin
    • 分子測定
    • 血液バンキング
  • Grifols
  • Blood Screening (Molecular PROCLEIX Tests)
  • Hologic
  • Molecular Cytology / Histology (HPV)
    • その他分子測定 (STIs, HIV, HCV, TB, 呼吸器系)
    • 微生物学 (AccuProbe Molecular Culture ID Tests)
    • 血液スクリーニング (Molecular PROCLEIX Tests)
  • Meridian Bioscience
  • OraSure Technologies
  • Ortho-Clinical Diagnostics
  • QIAGEN
    • 分子測定法
    • 免疫測定
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Bio-Rad Laboratories Inc.
  • Gen-Probe Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific Inc.

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI5721838

Infectious disease tests are one of the most dynamic spaces in the in vitro diagnostics (IVD) industry. Companies in the market need to stay aware of competitive trends and medical trends as occasional explosive market growth in the infectious disease test market can occur with the emergence of new disease threats or acceptance of new routine screening procedures.

This Kalorama Information report, The World Market for Infectious Disease Tests, contains detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening. POC and home testing markets for infectious disease are also provided. Specific market details provided include:

  • ID/AST Test Market by Type (Auto ID/AST Systems, Manual ID/AST Systems, Blood Culture, Chromogenic Media, Rapid Micro)
  • Infectious Disease ID/AST Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • ID/AST Leader Market Shares
  • Infectious Disease Immunoassays by Type (Lab-Based, POC, Home Testing)
  • Laboratory Infectious Disease Immunoassays Sales by Disease (Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, Sexually Transmitted Diseases, ToRCH, Others)
  • Infectious Disease Immunoassay Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • Infectious Disease Immunoassays Market Share
  • Infectious Disease Molecular Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • Infectious Disease Blood Screening Sales by Type- Immunoassays/NAT
  • Infectious Disease Blood Screening Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • Infectious Disease Blood Screening Test Market Shares

Infectious diseases are also the frequent target of novel technology applications including PCR-alternative molecular amplification methods, next-generation sequencing (NGS), microarrays, and mass spectrometry. Advancements in instrument automated analysis and microfluidics have allowed for the proliferation of infectious disease testing across settings and institutions - from traditional sites such as reference labs through physician office laboratories (POLs) and mobile clinics in the developing world.

Sales and forecasts of infectious disease reagents are made through to 2020. Emerging products and markets are described; key players and strategies discussed and competitive trends are analyzed.

In addition to providing useful market data for business planning efforts, the report covers important trends in the industry:

Globalization: The process of globalization is relevant to infectious disease through its erosion of spatial and temporal barriers to disease spread and the appropriately globalized response of governments and industry to infectious disease threats and burdens. The new global paradigm for infectious diseases has been demonstrated by several quickly mounting international disease outbreaks in this century - direct products of increased mobility and international trade - and increased engagement of developing world disease burdens by the global in vitro diagnostics (IVD) industry and international organizations. Globalization is also evident through the challenges posed by climate change to disease control and epidemiology.

Antibiotic Resistance: The development of modern healthcare systems across the world and the greater availability and over-prescription of antibiotics worldwide have aided the rise of antibiotic-resistant pathogens, particularly infectious bacteria and fungi in healthcare settings. The development of antimicrobial resistance (AMR) is one of the leading healthcare challenges worldwide, if not the leading existential threat to several healthcare practices. Resistant microbes are most often found in healthcare settings among inpatients left vulnerable to infection due to compromised immune systems, weakened health, or exposure through procedures and devices. The resistance is a product of the microbes' routine exposure to antibiotics or antimicrobials. The dearth of new antibiotic discovery has escalated the threat beyond individual patient outcomes to the underpinnings of modern therapies for infectious disease. According to market player Abbott Diagnostics, effective rapid testing and the earlier detection and identification of AMR and healthcare-acquired infections (HAIs) has the potential to reduce healthcare costs in sepsis and HAI cases by 30%.

Near-Patient For over the past decade, healthcare reform and technological improvements to analyzer and assay technologies have conspired to diversify and intensify point-of-care (POC) and near-patient testing. Near-patient testing includes tests performed in a physician office (either in exam room or dedicated space within office), any form of outpatient clinic (public health, rural, specialty, urgent care, retail), pharmacy, dialysis center, home, workplace, disaster response facility, nursing or long-term care facility, or outside of a centralized lab in a setting that significantly reduces time to results. Testing closer to a patient provides more timely diagnostic information for therapy, and potentially opens new possibilities in diagnosis and treatment in low-resource areas such as in the developing world and rural communities. The expansion of near-patient testing is impeded at times by its disadvantages compared to centralized laboratory testing that may include lower accuracy, precision, and higher test costs.

Major Companies, Profiled and Assessed

  • Alere
  • Beckman Coulter
  • Becton, Dickinson & Co. (BD)
  • bioMérieux
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostics Systems
  • DiaSorin
  • Grifols
  • Hologic
  • Meridian Bioscience
  • OraSure Technologies
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech

The information contained in this report has been assembled from primary and secondary data. Secondary data was collected from peer review journals and industry generated press releases. Primary research was conducted via telephone conversation with selected diagnostic marketers of in vitro diagnostics to assess the current market and trends in laboratory medicine.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Introduction
  • The Globalization of Infectious Diseases
  • Mounting Threat of Microbial Antibiotic Resistance
  • Near-Patient Testing
  • The Global Market for Infectious Disease Tests
    • ID/AST Market
    • Infectious Disease Immunoassay Market
    • Blood Screening Assay Market
  • Major Conclusions

TWO: INTRODUCTION TO INFECTIOUS DISEASES IN HEALTHCARE

  • Introduction to the Evolving World of Infectious Disease Testing
    • Public Health Response
    • Funding Sources
  • Leading Disease Threats
  • Leading Infetious Disease Testing Technologies
  • Point of View

THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES

  • Background
  • The Globalization of Infectious Diseases
    • Globalization Through Trade and Travel
    • Disease Burdens in Developing World
  • Vaccines
  • Mounting Threat of Microbial Antibiotic Resistance
  • Near-Patient Testing
  • New Technology Platforms in Infectious Disease Testing
    • Real-Time PCR
    • Alternative Nucleic Acid Amplification Methods
    • Loop-mediated isothermal amplification (LAMP)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Strand Displacement Amplification (SDA)
    • Helicase Dependent Amplification (HDA)
    • Nucleic Acid Sequence-Based Amplification (NASBA
    • Transcription-mediated amplification (TMA)
    • Sequencing
    • Mass Spectrometry
    • Flow Cytometry
  • Conclusions

FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET

  • Background
    • The World Market for Infectious disease Tests
    • Infectious Disease Test Markets - ID/AST, Immunoassays, Molecular Assays
    • Major Competitors in the Global Infectious Disease Test Market
    • Market-Leading Infectious Diseases

FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING

  • Background
  • Liquid Microbiology and ID/AST Automation
  • Market Analysis
  • Regional Breakout
  • Market Share
    • Rapid Tests
    • Microbial Identification and Antimicrobial Susceptibility Systems
    • Chromogenic Media
    • Blood Culture
    • Vendor Developments in Blood Culture ID Testing
  • Market Outlook for ID/AST Testing

SIX: THE MARKET FOR IMMUNOASSAYS

  • Background
  • Sepsis Serology
  • Hepatitis
  • HIV
  • Mycology
  • Parasitology
  • Respiratory
  • ToRCH
  • Sexually Transmitted Diseases (STDs)
  • Regional Breakout
  • Market Outlook for Immunoassay Infectious Disease Testing

SEVEN: THE MARKET FOR MOLECULAR ASSAYS

  • Background
  • Market Analysis
    • HAI Market
    • HIV Market
    • Hepatitis Market
    • Chlamydia/Gonorrhea (CT/NG)
    • HPV
    • Respiratory
    • Mycobacteria/TB
    • Other
  • CT/NG, HPV and Sexual Health / Women's Health
  • Healthcare-Acquired Infections (HAIs) / Antimicrobial Resistance (AMR)
  • HIV
  • Respiratory
  • Market Outlook for Molecular Infectious Disease Testing

EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET

  • Commonly Tested Pathogens in Blood Screening
  • Market Analysis by Type
  • Vendor Market Share
  • Immunoassays
  • Nucleic Acid Tests (NATs)
  • Nucleic Acid Test Introductions and Innovations

NINE: COMPANY PROFILES

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter (Danaher)
  • Becton, Dickinson & Co. (BD)
  • bioMérieux
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Copan Diagnostics
  • DiaSorin
    • Molecular
    • Blood Banking
  • Grifols
  • Blood Screening (Molecular PROCLEIX Tests)
  • Hologic
  • Molecular Cytology / Histology (HPV)
    • Other Molecular (STIs, HIV, HCV, TB, Respiratory)
    • Microbiology (AccuProbe Molecular Culture ID Tests)
    • Blood Screening (Molecular PROCLEIX Tests)
  • Meridian Bioscience
  • OraSure Technologies
  • Ortho-Clinical Diagnostics
  • QIAGEN
    • Molecular Diagnostics
    • Immunoassays
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech

LIST OF EXHIBITS

  • ONE: EXECUTIVE SUMMARY
  • Figure 1-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year(30 EEA Member Countries/2004-2013) - Methicillin Resistant S. aureus (MRSA)
  • Figure 1-2: Worldwide Infectious Disease Test Market by Region
  • Table 1-2: Worldwide Infectious Disease Test Market by Region/Country North America, Western Europe (EU), Japan, China, India, Latin America,Rest of the World (ROW) (2015-2020)
  • Table 1-3: Worldwide Infectious Disease Test Market by Test Segment - LaboratoryImmunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020)
  • THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES
  • Table 3-1: Infectious Diseases of Globalization and Their Drivers
  • Table 3-2: Disease Preventable Vaccines in 2015
  • Table 3-3: Preventive Vaccines in Development for Infectious Diseases (2015)
  • Figure 3-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) - E. coli Resistance to Third-Generation Cephalosporins
  • Figure 3-2: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) - K. pneumoniae Multidrug Resistance to Third-Generation Cephalosporins, Fluoroquinolones and Aminoglycosides
  • Figure 3-3: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) - Methicillin Resistant S. aureus (MRSA)
  • Table 3-4: Selected Advanced Antibiotic Resistance Tests
  • Table 3-5: Selected Antibiotic Resistance Facts (CDC)
  • Table 3-6: Selected Advanced Near-Patient Infectious Disease Testing Platforms
  • Table 3-7: Selected Microorganisms and Their Associated Diseases
  • Table 3-8: Selected Isothermal Amplification Methods and Platform Examples
  • Table 3-9: Selected Next Generation Sequencers for Infectious Disease Applications
  • Table 3-10: Selected Infectious Disease Sequencing Innovations
  • Table 3-11: Selected Mass Spectrometry Microbiology Platforms
  • Table 3-12: Selected Flow Cytometry Infectious Disease Applications
  • FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET
  • Table 4-1: Worldwide Infectious Disease Test Market by Region/Country - North America, Western Europe (EU), Japan, China, India, Latin America, Rest of the World (ROW) (2015-2020)
  • Table 4-2: Worldwide Infectious Disease Test Market by Test Segment - Laboratory Immunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020) ($ millions)
  • Table 4-3: Global Infectious Disease Test Market Shares - Abbott Diagnostics, Alere, Beckman Coulter, BD, bioMérieux, Bio-Rad Labs, Cepheid, DiaSorin, Grifols, Hologic, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Others (%)
  • Table 4-4: Worldwide Infectious Disease Test Market by Major Diseases - HAI / AMR, Hepatitis, HIV, Respiratory, STDs / Women's Health, Other Infectious Diseases (2015) ($ millions)
  • FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING
  • Table 5-1: Microbiology Sample/Specimen Types Ranked by Average Volume
  • Table 5-2: Worldwide ID/AST Sales by Segment - Panels and Reagents, Blood Culture, Chromogenic Media, Rapid Micro (2015-2020) ($ millions)
  • Table 5-3: Worldwide ID/AST Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020) ($ millions)
  • Table 5-4: ID/AST Leader Market Shares - BD, Beckman Coulter, bioMérieux, Thermo Fisher Scientific, Others
  • Table 5-5: Selected ID/AST System Innovations
  • Table 5-6: Selected Chromogenic Media Innovations and Launches
  • Table 5-7: Selected Blood Culture Innovations and Launches
  • SIX: THE MARKET FOR IMMUNOASSAYS
  • Table 6-1: Selected Sepsis Serology Innovations
  • Table 6-2: Worldwide Infectious Disease Immunoassay Sales by Segment - Lab-Based, Rapid / POC (2015-2020) ($ millions)
  • Table 6-3: Worldwide Infectious Disease Immunoassay Sales by Region - North America, Western Europe, Japan, China, India, Latin America,
  • ROW (2015-2020) ($ millions)
  • Table 6-4 Alere, Beckman Coulter, bioMérieux, Bio-Rad Laboratories, DiaSorin, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Trinity Biotech, Others
  • Table 6-5: Laboratory Infectious Disease Immunoassays Sales by Disease or Pathogen - Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, Sexually Transmitted Diseases (STDs), ToRCH, Others (2015)
  • Table 6-6: Selected Laboratory Infectious Disease Immunoassay Innovations
  • Table 6-7: CLIA-Waived Infectious Disease Tests and Analytes
  • Table 6-8: Rapid Infectious Disease Immunoassays Sales by Disease or Pathogen - C. difficile, E. coli, H. pylori, Hepatitis, HIV, Influenza, Malaria, Strep A, STDs, Others (2015)
  • Table 6-9: Selected Rapid Infectious Disease Immunoassay Innovations
  • SEVEN: THE MARKET FOR MOLECULAR ASSAYS
  • Table 7-1: Selected Moderate and Waived Complexity Molecular Infectious Disease Testing Platforms
  • Table 7-2: Worldwide Molecular Infectious Disease Assay Sales by Disease Area - CT/NG, HAIs, Hepatitis, HIV, HPV, Mycobacteria/TB,
  • Respiratory, Others (2015-2020)
  • Table 7-3 bioMérieux, Cepheid, Hologic, QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Others
  • Table 7-4: Selected Molecular Sexual Health and Women's Health Test Introductions and Innovations
  • Table 7-5: Selected Molecular Healthcare-Acquired Infection (HAI) / Antimicrobial Resistance (AMR) Test Introductions and Innovations
  • Table 7-6: Selected Molecular Hepatitis Test Introduction and Innovations
  • Table 7-7: Selected Molecular HIV Test Introduction and Innovations
  • Table 7-8: Selected Molecular Respiratory Infection Test Introduction and Innovations 178
  • EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET
  • Table 8-1: Commonly Tested Pathogens in Blood Screening
  • Table 8-2: Worldwide Infectious Disease Blood Screening Test Sales - Immunoassays and Nucleic Acid Tests (NATs) (2015-2020) ($ millions)
  • Table 8-3: Infectious Disease Blood Screening Test Market Shares - Abbott Diagnostics, DiaSorin, Grifols, Hologic, Ortho-Clinical Diagnostics, Roche Diagnostics, Others
  • Table 8-4: Selected Blood Screening Immunoassay Introductions and Innovations Nucleic Acid Tests (NATs)
  • Table 8-5: Selected Blood Screening Nucleic Acid Test Introductions and Innovations.. 195
  • NINE: COMPANY PROFILES
  • Table 9-2: Alere Revenue (2011-2014)
  • Table 9-3: Beckman Coulter Revenue (2011-2014)
  • Table 9-4: Becton, Dickinson & Co. (BD) Revenue (FY 2011-2014)
  • Table 9-5: bioMérieux Revenue (2011-2014)
  • Table 9-6: Bio-Rad Laboratories Revenue (2011-2014)
  • Table 9-7: Cepheid Revenue (2011-2014)
  • Table 9-8: Chembio Diagnostics Systems Revenue (2011-2014)
  • Table 9-9: DiaSorin Revenue (2011-2014)
  • Table 9-10: Grifols Revenue (2011-2014)
  • Table 9-11: Hologic Revenue (FY 2011-2014)
  • Table 9-12: Meridian Bioscience Revenue (2011-2014)
  • Table 9-13: OraSure Technologies Revenue (2011-2014)
  • Table 9-14: Ortho-Clinical Diagnostics Revenue (2011-2014)
  • Table 9-15: QIAGEN Revenue (2011-2014)
  • Table 9-16: Quidel Corporation Revenue (2011-2014)
  • Table 9-17: Roche Diagnostics Revenue (2011-2014)
  • Table 9-18: Siemens Healthcare Diagnostics Revenue (FY 2011-2014)
  • Table 9-19: Thermo Fisher Scientific Revenue (2011-2014)
  • Table 9-20: Trinity Biotech Revenue (2011-2014)
Back to Top